Mirdametinib (PD0325901) (GMP) is Mirdametinib (HY-10254) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Mirdametinib is an orally active, selective and non-ATP-competitive MEK inhibitor[1][2][3].
Molecular Weight:
482.19
CAS Number:
[391210-10-9]
Formula:
C16H14F3IN2O4
Target:
MEK
Application Notes:
MCE Product type: GMP Small Molecules
* VAT and and shipping costs not included. Errors and price changes excepted